Biohacking Kompakt

Supplement

Beta-glucan

Probiotics · β-glucan, oat beta-glucan, barley beta-glucan, oat bran, yeast beta-glucan, beta-1,3/1,6-glucan, Wellmune, Yestimun, lentinan

Beta-glucan is a dietary fiber found in oats, barley, yeast and mushrooms. From oats and barley, it is one of the few plant substances whose cholesterol-lowering effect the EU officially recognizes. Yeast and mushroom glucans, by contrast, are marketed for the immune system, and there the evidence is considerably thinner.

In short

Beta-glucan from oats and barley lowers LDL cholesterol, supported by dozens of randomized trials. From 3 g per day, LDL falls by 0.19 to 0.25 mmol/l in the meta-analyses, and the EU permits a health claim for this. Eaten with a meal, it also dampens the rise in blood sugar. The catch: the effect depends on viscosity, and isolated and broken-down extracts often work less well than whole oats. Yeast beta-glucan shows a signal against colds, but from small, inconsistent studies.

What it is

Beta-glucans are chains of glucose units that our gut cannot digest. The name sounds like a single substance but describes a whole family. What matters is where the beta-glucan comes from, because structure and effect depend on it.

Beta-glucan from oats and barley sits in the cell walls of the grain, especially in the bran. It dissolves in the gut and makes the food pulp viscous. The cholesterol and blood sugar data refer to this form. Beta-glucan from baker’s yeast and from mushrooms such as shiitake, reishi or chaga is branched differently and largely insoluble. This form is studied mainly for possible effects on immune cells. Anyone buying a product should therefore look at the source first.

How it is supposed to work

For oats and barley, the mechanism is fairly well understood in humans. The dissolved beta-glucan forms a viscous layer in the small intestine that binds bile acids and excretes them with the stool. The liver has to make new bile acids and takes the cholesterol for this from the blood. In a study of people with an ileostomy, bile acid excretion rose by 144 percent with native oat beta-glucan, but not with enzymatically broken-down beta-glucan. The same viscosity delays the entry of sugar from the meal into the blood.

This leads to an important limitation: the shorter the beta-glucan chains, the thinner and the weaker. In a large study, low-molecular-weight oat beta-glucan was only half as effective as the long variant and was no longer significant. Processing, baking and extraction can shorten the chains.

Yeast and mushroom glucans are said to work differently. Immune cells carry a receptor called Dectin-1, which recognizes beta-glucans from fungal and yeast cell walls and thus helps detect fungi. The idea is that swallowed glucans put the immune defense on standby via immune cells in the gut. Receptor binding is demonstrated in cell and mouse studies; how much of it reaches humans after swallowing has not been measured.

What users are looking for

Most people turn to beta-glucan because of elevated cholesterol levels, often as oat bran in muesli, as a powder or in capsules. Others use yeast beta-glucan in winter against colds or mushroom extracts as general immune support. Many report better blood lipid values at their next check-up after a few weeks of oat bran, and longer-lasting satiety. These are experience reports that fit the study evidence well for cholesterol, but go beyond what has been shown in controlled studies for the immune effect.

What is well supported

Best supported is the lowering of LDL cholesterol by oat beta-glucan. A meta-analysis of 28 randomized trials found, with at least 3 g per day, 0.25 mmol/l lower LDL and 0.30 mmol/l lower total cholesterol, with no effect on HDL and triglycerides. The largest analysis to date, with 58 trials and 3,974 participants, found 0.19 mmol/l lower LDL; non-HDL cholesterol and apolipoprotein B also fell. In people with already elevated values, the effect was somewhat larger at 0.27 mmol/l in a meta-analysis of 13 trials. For barley, a meta-analysis of 14 trials likewise shows 0.25 mmol/l lower LDL. The EU has therefore authorized health claims for beta-glucan from oats and barley, for oats even as a claim on reducing a risk factor for coronary heart disease.

There is also an authorized claim for blood sugar: at least 4 g of beta-glucan per 30 g of available carbohydrates dampens the rise after the meal. In 2026, EFSA additionally confirmed that oat beta-glucan lowers the blood sugar peak after a meal. In type 2 diabetes, the long-term marker HbA1c fell by 0.21 percentage points in a small meta-analysis.

What the studies show

The large oat meta-analysis

Researchers from Toronto analyzed 58 randomized trials with 3,974 participants that ran for at least three weeks. With a median of 3.5 g of oat beta-glucan per day, LDL cholesterol, non-HDL cholesterol and apolipoprotein B fell significantly. The results of the individual trials, however, varied widely, which points to differences in product and processing.

The molecular weight study

345 adults with slightly elevated LDL ate breakfast cereals for four weeks containing oat beta-glucan of different chain lengths or wheat fiber. 3 g of the long-chain variant lowered LDL by 0.21 mmol/l, that is 5.5 percent. The short-chain variant, despite an amount of 4 g, was only half as effective and not significant. The study shows that viscosity determines the effect.

The yeast glucan winter study

299 healthy adults who had had at least three colds in the previous year took 900 mg of yeast beta-glucan or placebo for 16 weeks. At the end, the same number had caught a cold: 71 versus 70. The physical symptoms, however, were significantly milder in the first week of a cold. The result fits a meta-analysis of 13 studies that found fewer infections, but also shows how small and inconsistent the effect is.

Where the data stop

The cholesterol data come from studies lasting mostly 2 to 12 weeks, and their endpoint is LDL, not heart attack. That lower LDL protects the heart is well established, but there is no dedicated study with beta-glucan and hard endpoints such as heart attacks or mortality. More important for everyday life is the product question. Isolated beta-glucan extracts perform worse than oats themselves: in a small Danish study with 14 participants, extracted oat and barley glucans did not change cholesterol compared with control, and a meta-analysis of 18 studies found an effect on blood sugar and HbA1c only for whole oat products and oat bran, not for extracts.

For yeast and mushroom glucans, the picture is more open. The infection studies are small, often supported by the manufacturer and very different from one another. In a study with 50 older adults per group, the difference in confirmed infections was not significant. There is no authorized EU claim on the immune system for any beta-glucan; EFSA rejected a corresponding application for a yeast glucan in 2010. For mushroom glucans, robust human data exist mainly for lentinan from shiitake: added to chemotherapy in advanced gastric cancer, it prolonged survival in an analysis of 650 patients. That is a use in cancer treatment under medical supervision and says nothing about over-the-counter mushroom capsules. I found no human data on longevity endpoints.

Status, approval and legal

Oats, oat bran and barley are ordinary foods; beta-glucan from them may be sold as a food ingredient and as a dietary supplement. EU Regulation 432/2012 permits the claim that beta-glucans contribute to the maintenance of normal blood cholesterol levels if a portion contains at least 1 g and reference is made to the effect at 3 g per day. In addition, there is the blood sugar claim and, under Regulation 1160/2011, a claim on lowering cholesterol as a risk factor for coronary heart disease. These claims apply only to beta-glucan from oats and barley. Yeast beta-glucan has been authorized as a novel food since 2011; there is no health claim for it. Maximum amounts from BfR or DGE do not exist. Beta-glucan is not on the WADA Prohibited List 2026.

Safety

Beta-glucan is well tolerated, in studies up to 28 g per day. Because it is a fermentable fiber, bloating and soft stools can occur, especially at the beginning; in one study with 3.5 g per day, three participants dropped out because of diarrhea. Increasing slowly and drinking enough helps many people. EFSA has assessed yeast beta-glucan as safe and did not rate the allergy risk higher than for other products containing baker’s yeast. I found no robust human data on interactions with medications. Anyone taking cholesterol-lowering drugs should not replace them with oat bran but discuss changes with a physician. In celiac disease, look for oat products labeled gluten-free.

BK-Score Supported, with caveats

Human evidence7
Mechanism7
Safety data7
Hype gap6
Track record of use8

Evidence 7, because many RCTs and several consistent meta-analyses show LDL lowering by oat and barley beta-glucan (Whitehead 2014: 28 RCTs, -0.25 mmol/l; Ho 2016: 58 RCTs with 3,974 participants, -0.19 mmol/l; Ho 2016 barley: 14 RCTs, -0.25 mmol/l) and EFSA recognizes the effect, but the endpoint remains a surrogate marker, the studies ran only 2 to 12 weeks and heterogeneity is high (I² = 79 %). Mechanism 7, because the causal chain has been shown in humans – bile acid excretion +144 % with native, not with hydrolyzed beta-glucan (Ellegård 2007), and LDL lowering dependent on molecular weight (Wolever 2010) – while the immune effect of yeast and mushroom glucans via Dectin-1 comes only from cell and animal studies. Safety 7, because controlled data over weeks to months are available, beta-glucan was well tolerated up to 28 g per day (Mysonhimer 2022) and EFSA assessed yeast beta-glucan as safe (2011), but systematic long-term monitoring of extracts is missing. Hype 6, because cholesterol marketing largely matches the evidence, but immune promises for yeast and mushroom glucans go beyond small, heterogeneous studies (Zhong 2021) and EFSA rejected an immune claim in 2010. Use 8, because oats and barley have been eaten for decades and the health claims have been regulated in the EU since 2011. Direction positive: for cholesterol the data clearly point in one direction; for the immune system the picture is more open.

The score rates the state of knowledge, not the substance. “Safety data 9” means well studied – not harmless.
Subjective assessment by Biohacking Kompakt based on published scoring rules – not a scientific rating and not a medical recommendation. Rules and all ratings (German)

Frequently asked questions about beta-glucan

How much beta-glucan lowers cholesterol?

The authorized EU claim names 3 g of beta-glucan from oats or barley per day. In the meta-analyses, LDL fell by 0.19 to 0.25 mmol/l with this. The effect appeared after a few weeks.

Is oat bran better than beta-glucan capsules?

According to the studies, there is a fair amount in favor of it. Whole oat products and oat bran improved blood sugar values; isolated extracts did not. In addition, beta-glucan works only if the chains are long enough to become viscous in the gut.

Does beta-glucan strengthen the immune system?

For yeast beta-glucan there are studies with fewer or milder colds, but they are small and inconsistent. There is no authorized health claim on the immune system in the EU. EFSA rejected such an application in 2010.

What is the difference between oat beta-glucan and yeast beta-glucan?

Oat beta-glucan is soluble and acts on cholesterol and blood sugar through viscosity in the gut. Yeast and mushroom glucans are structured differently and are studied for possible effects on immune cells. The cholesterol claim applies only to oats and barley.

Does beta-glucan have side effects?

Bloating and soft stools are possible, especially at the beginning. In studies, beta-glucan was well tolerated up to 28 g per day. Increasing slowly and drinking enough helps.

Does beta-glucan help against high blood sugar?

Eaten with a meal, beta-glucan from oats or barley dampens the rise in blood sugar; there is an authorized EU claim for this. In type 2 diabetes, HbA1c fell slightly in a small meta-analysis. It does not replace diabetes treatment.

Related

Sources

Open in the database – with search, filters and comparison (German app)

Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-09-29.